Website & contact details
- Website
Not loaded yet. See them on Companies House
People and entities with significant control, from the Companies House PSC register
Balance sheet as at 31 March 2026 · total exemption full accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £36,446 | £53,602 | £8,970 | £12,398 | £24,701 | £37,004 | £49,307 |
| Current Assets | £299,353 | £685,697 | £60,943 | £101,590 | £117,637 | £133,846 | |
| Cash | £168,464 | £152,119 | £646,676 | £15,828 | £65,665 | £41,284 | £72,687 |
| Creditors (< 1 year) | £45,090 | £50,074 | £15,612 | £13,780 | £18,340 | £9,271 | £11,722 |
| Net Current Assets | £249,279 | £670,085 | £47,163 | £83,250 | £108,366 | £122,124 | |
| Net Assets | £214,961 | £302,881 | £679,055 | £59,561 | £107,951 | £145,370 | £171,431 |
| Shareholder Funds | £214,961 | £302,881 | £679,055 | £59,561 | £107,951 | £145,370 | £171,431 |
“Transforming orthopaedics and regenerative medicine through pioneering use of nanoclay gels stemming from world-class stem cell research”
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 July 2026 | Total exemption full accounts | 31 March 2026 | ||
| 26 November 2025 | Confirmation statement with no updates | 22 November 2025 | ||
| 11 August 2025 | Total exemption full accounts | 31 March 2025 | ||
| 8 March 2025 | Termination of appointment of a director | |||
| 22 November 2024 | Confirmation statement with no updates | 22 November 2024 |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →